Could things go from bad to worse for Neil Woodford?

Could more underperformance be ahead for Neil Woodford?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This year has been one to forget for Neil Woodford. His investment decision-making ability has been questioned by a wide range of investors after a poor performance by his standards. His funds have generally underperformed their benchmarks, and this has led to his reputation suffering at least some damage.

Looking ahead, his fund performance may deliver strong returns in the long run. However, in the short run things could realistically go from bad to worse.

Big calls

One of the major decisions made by Neil Woodford this year has been to sell stakes in long-held companies such as GlaxoSmithKline and British American Tobacco. At the same time, he has purchased a large stake in Lloyds which makes it the fifth biggest holding in his UK Equity Income fund.

While in the long run Lloyds could perform well and deliver high returns, the reality is that the UK economy faces a highly challenging period. Brexit has caused confidence to fall, which has helped to move inflation higher. With consumer spending likely to come under pressure due to falling real disposable incomes, the economic outlook for the UK seems tough. This could hurt the performance of banking stocks such as Lloyds. With the bank operating almost exclusively in the UK, its share price could come under pressure.

Although Lloyds makes up just 3.1% of Neil Woodford’s UK Equity Income fund, his decision to make it one of his top holdings could be scrutinised by investors. Should the bank’s share price fall in the short run, it may be viewed as another ‘error’ by the star fund manager.

Likewise, if Brexit negotiations continue to move along at a slow pace and the pound continues to weaken as the prospect of a ‘no deal’ builds, international stocks such as GlaxoSmithKline and British American Tobacco may see their share prices rise in the short run. Having sold them recently, this could be seen as a further mistake by Woodford.

Long-term potential

Of course, he has been in a similar position before. During the dotcom bubble he was viewed as being out of touch with a new growth avenue. He sat out the bubble and endured criticism for doing so – until it burst and suddenly he was back in fashion once more. Therefore, a similar journey may be ahead this time around.

Certainly, his short-term performance has been disappointing. But the reality is that no investment style, strategy or fund manager can constantly stay ahead of their benchmark. Sometimes one strategy is successful for a period, then events happen and change the market. This can mean what was successful last year is no longer a worthwhile strategy – as was the case regarding the dotcom bubble and subsequent crash.

While things may get worse before they get better for Neil Woodford, in the long run he could be proved right in his decisions. With his reputation being somewhat less impressive than it once was, now could be the perfect time to buy his funds for the long term.

Peter Stephens owns shares in GlaxoSmithKline, British American Tobacco and Lloyds. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Aviva logo on glass meeting room door
Investing Articles

After falling another 5%, are Aviva shares too cheap to ignore?

£10,000 invested in Aviva shares five years ago would have grown 50% by now. But what might the future hold,…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

Next impresses again, but could its shares be about to crash?

Next shares have leapt after the retailer raised its full-year profits guidance. But could the FTSE 100 retailer be running…

Read more »

Investing Articles

Time to buy, after Next shares are lifted by storming FY results?

Retail sector weakness is holding back Next shares, is it? Tell that to the fashion shoppers who've driven up full-year…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Growth Shares

Why the Barclays share price is currently its most undervalued in months

Jon Smith talks through why the Barclays share price has struggled in recent weeks, and flags up reasons why it…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

10.7% yield! Should investors snap up Taylor Wimpey shares before they go ex-dividend on 2 April?

Harvey Jones is stunned by the double-digit yield available from Taylor Wimpey shares. But the FTSE 250 stock comes with…

Read more »

White female supervisor working at an oil rig
Investing For Beginners

Are investors taking a massive gamble with the Shell share price?

Jon Smith mulls the current state of play in the oil market and explains why he thinks further gains for…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

Stock market correction 2026: a rare chance to scoop up cheap UK shares?

The UK stock market's officially in a correction after a sharp drop in UK share prices, but our writer sees…

Read more »

Investing Articles

How much do you need in an ISA to aim for a £750 monthly second income?

Harvey Jones crunches the numbers to show how investors could aim for a high-and-rising second income from dividend-paying FTSE 100…

Read more »